Research ArticleOriginal Article
Efficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancer
Xinyi Zhou, Qian Xiao, Dongliang Fu, Haochen Zhang, Yang Tang, Jinjie He, Yeting Hu, Xiangxing Kong, Fei Teng, Xiangrui Liu, Ying Yuan and Kefeng Ding
Cancer Biology & Medicine February 2022, 19 (2) 213-228; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0532
Xinyi Zhou
1Department of Colorectal Surgery and Oncology, Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China
Qian Xiao
1Department of Colorectal Surgery and Oncology, Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China
Dongliang Fu
1Department of Colorectal Surgery and Oncology, Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China
Haochen Zhang
2Department of Medical Oncology, Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China
Yang Tang
1Department of Colorectal Surgery and Oncology, Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China
Jinjie He
1Department of Colorectal Surgery and Oncology, Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China
Yeting Hu
1Department of Colorectal Surgery and Oncology, Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China
Xiangxing Kong
1Department of Colorectal Surgery and Oncology, Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China
Fei Teng
3Hangzhou Oncocare Co Ltd, Hangzhou 310009, China
Xiangrui Liu
4Department of Pharmacology, Zhejiang University School of Medicine, Hangzhou 310058, China
Ying Yuan
2Department of Medical Oncology, Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China
Kefeng Ding
1Department of Colorectal Surgery and Oncology, Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China
5Cancer Center, Zhejiang University, Hangzhou 310009, China
References
- 1.↵
- 2.↵
- 3.↵
- Van Cutsem E,
- Peeters M,
- Siena S,
- Humblet Y,
- Hendlisz A,
- Neyns B, et al.
- 4.↵
- Pylayeva-Gupta Y,
- Grabocka E,
- Bar-Sagi D.
- 5.↵
- 6.↵
- 7.↵
- Russo M,
- Di Nicolantonio F,
- Bardelli A.
- 8.↵
- Reddy MV,
- Venkatapuram P,
- Mallireddigari MR,
- Pallela VR,
- Cosenza SC,
- Robell KA, et al.
- 9.↵
- Dai YH,
- Hung LY,
- Chen RY,
- Lai CH,
- Chang KC.
- 10.↵
- 11.↵
- 12.↵
- 13.↵
- Foster SA,
- Malek S.
- 14.↵
- Boutin AT,
- Liao WT,
- Wang M,
- Hwang SS,
- Karpinets TV,
- Cheung H, et al.
- 15.↵
- Vartanian S,
- Bentley C,
- Brauer MJ,
- Li L,
- Shirasawa S,
- Sasazuki T, et al.
- 16.↵
- Shirasawa S,
- Furuse M,
- Yokoyama N,
- Sasazuki T.
- 17.↵
- 18.↵
- Liu Y,
- He J,
- Xu J,
- Li J,
- Jiao Y,
- Bei D, et al.
- 19.↵
- Remmele W,
- Stegner HE.
- 20.↵
- Fulda S,
- Debatin KM.
- 21.↵
- 22.↵
- Amodio V,
- Yaeger R,
- Arcella P,
- Cancelliere C,
- Lamba S,
- Lorenzato A, et al.
- 23.↵
- Chapman CM,
- Sun X,
- Roschewski M,
- Aue G,
- Farooqui M,
- Stennett L, et al.
- 24.↵
- Montor WR,
- Salas A,
- Melo FHM.
- 25.↵
- 26.↵
- Hallin J,
- Engstrom LD,
- Hargis L,
- Calinisan A,
- Aranda R,
- Briere DM, et al.
- 27.↵
- Yang Q,
- Huo S,
- Sui Y,
- Du Z,
- Zhao H,
- Liu Y, et al.
- 28.↵
- Holkova B,
- Zingone A,
- Kmieciak M,
- Bose P,
- Badros AZ,
- Voorhees PM, et al.
- 29.↵
- Ganesan P,
- Janku F,
- Naing A,
- Hong DS,
- Tsimberidou AM,
- Falchook GS, et al.
- 30.↵
- Engelman JA,
- Chen L,
- Tan X,
- Crosby K,
- Guimaraes AR,
- Upadhyay R, et al.
- 31.↵
- Schram AM,
- Gandhi L,
- Mita MM,
- Damstrup L,
- Campana F,
- Hidalgo M, et al.
- 32.↵
- Gumireddy K,
- Reddy MV,
- Cosenza SC,
- Boominathan R,
- Baker SJ,
- Papathi N, et al.
- 33.↵
- Steegmaier M,
- Hoffmann M,
- Baum A,
- Lénárt P,
- Petronczki M,
- Krssák M, et al.
- 34.↵
- 35.↵
- Jiang CC,
- Lai F,
- Thorne RF,
- Yang F,
- Liu H,
- Hersey P, et al.
- 36.↵
- Liu Z,
- Wang M,
- Wang H,
- Fang L,
- Gou S.
- 37.↵
In this issue
Efficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancer
Xinyi Zhou, Qian Xiao, Dongliang Fu, Haochen Zhang, Yang Tang, Jinjie He, Yeting Hu, Xiangxing Kong, Fei Teng, Xiangrui Liu, Ying Yuan, Kefeng Ding
Cancer Biology & Medicine Feb 2022, 19 (2) 213-228; DOI: 10.20892/j.issn.2095-3941.2020.0532
Efficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancer
Xinyi Zhou, Qian Xiao, Dongliang Fu, Haochen Zhang, Yang Tang, Jinjie He, Yeting Hu, Xiangxing Kong, Fei Teng, Xiangrui Liu, Ying Yuan, Kefeng Ding
Cancer Biology & Medicine Feb 2022, 19 (2) 213-228; DOI: 10.20892/j.issn.2095-3941.2020.0532
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.